Lidexa
PrescriptionТорговые наименования: Lidexa
About This Medication
DESCRIPTION Lidexa™ (Lidocaine Hydrochloride) Cream 38.8
Действующие Вещества
| Компонент | Дозировка |
|---|---|
| Lidocaine | - |
Показания и Применение
Дозировка и Способ Применения
Side Effects Overview
Предупреждения и Меры Предосторожности
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Противопоказания
CONTRAINDICATIONS Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Frequently Asked Questions
INDICATIONS AND USAGE Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
DOSAGE AND ADMINISTRATION For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
CONTRAINDICATIONS Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Lidexa is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Lidexa drug label (National Library of Medicine)
- • openFDA — Lidexa label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 1723991 (NLM Normalized Drug Names)
- • NDC Directory — Lidexa (FDA National Drug Code)
Медицинский Отказ от Ответственности
Информация на данной странице предназначена исключительно в образовательных целях и не должна использоваться в качестве замены профессиональной медицинской консультации, диагностики или лечения.
Всегда обращайтесь за советом к своему врачу или иному квалифицированному медицинскому работнику по любым вопросам, связанным с состоянием здоровья или лекарственными препаратами.
Источники данных: DailyMed (NLM), openFDA, MFDS